Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma

Liyan Jin,Xinyue Su,Wenjing Li,Jie Wu,Hua Zhang

DOI: https://doi.org/10.1038/s41598-024-56408-4

IF: 4.6

2024-03-10

Scientific Reports

Abstract:Due to the long-term low survival rates of gastric adenocarcinoma (GAC) patients, the occurrence and prognosis of second primary malignancies (SPMs) are often underreported and overlooked as a significant concern.To date, only a few studies have addressed this issue in the context of GAC. These studies, however, are limited by their small patient cohorts and lack of substantial, meaningful findings. Our study aims to fill this gap by investigating the incidence, risk factors, and prognostic significance of SPMs among GAC survivors. Utilizing the Surveillance, Epidemiology, and End Results (SEER) database, we analysed data from patients diagnosed with GAC between 2000 and 2020. The study employs the standardized incidence ratio (SIR) to assess the relative risk of SPMs, competing risk regression to identify risk factors for SPM development after GAC, and Kaplan-Meier and COX regression analyses for survival outcomes. Out of 44,041 GAC patients analyzed, 2,032 (4.3%) developed SPMs, with a median latency period of 36 months. The incidence of SPMs was significantly higher in GAC patients (SIR 1.36, 95% CI 1.32-1.4, EAR 53.57) compared to the general population. Key factors including older age, sex, tumor grade, summary stage, and history of surgical and radiation therapy were related to the higher risk of developing SPMs following GAC. Interestingly, GAC patients without SPMs exhibited poorer overall survival compared to those with SPMs. Age, summary stage, and surgical history were identified as independent prognostic factors for GAC patients with SPMs. This comprehensive analysis underscores the necessity of vigilant monitoring and tailored follow-up for SPMs in GAC survivors, highlighting the study's contribution to enhancing GAC survivors care strategies.

multidisciplinary sciences

What problem does this paper attempt to address?

This paper aims to address the incidence, risk factors, and prognosis of second primary malignancies (SPMs) in patients with gastric adenocarcinoma (GAC). Due to the low long-term survival rate of GAC patients, the occurrence and prognosis of SPMs are often overlooked. Currently, there are few studies on this issue with limited sample sizes and a lack of substantial findings. This study evaluates the incidence of SPMs by analyzing data from 44,041 patients diagnosed with gastric adenocarcinoma between 2000 and 2020 in the US SEER database, and explores related risk factors and survival outcomes using standardized incidence ratios (SIR), competing risk regression, Kaplan-Meier, and COX regression analysis. The study found that 2,032 (4.3%) of these patients developed SPMs within a median latency period of 36 months, with an incidence significantly higher than that of the general population (SIR 1.36, 95% CI 1.32-1.4). Key factors associated with an increased risk of SPMs included older age, gender, tumor grade, summary stage, and history of surgery and radiotherapy. Interestingly, GAC patients without SPMs had a poorer overall survival rate. Additionally, age, summary stage, and history of surgery were identified as independent prognostic factors for GAC patients with SPMs. This study highlights the importance of monitoring SPMs in GAC survivors and provides a basis for improving care strategies.

Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma

Effect of Prior Malignancy on the Prognosis of Gastric Cancer and Somatic Mutation.

Prognostic Similarities Between Gastric Adenosquamous Carcinoma and Typical Gastric Adenocarcinoma: A Large Population-Based and Propensity Score-Matched Study.

Second Primary Malignancy among Malignant Solid Tumor Survivors Aged 85 Years and Older

Analyzing risk factors for second malignancies in early gastric carcinoma from the SEER database

The Impact of a Prior Malignancy on Outcomes in Gastric Cancer Patients

Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study

A Population-Based and Propensity Score-Matched Investigation of the Occurrence, Management, and Prognosis of Anal Mucinous Adenocarcinoma Patients

Influence of Primary Tumor Resection on Survival of Patients with Metastatic Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Analysis

Risk of Second Primary Cancers among Long-Term Survivors of Breast Cancer

Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis

Association of Second Primary Malignancy and Long-Term Survival Outcomes in Patients with Head and Neck Cancer

Second Primary Malignancies in Patients With Hepatocellular Carcinoma: A Population-Based Analysis

Second Primary Malignancy in Patients with Cholangiocarcinoma: a Population-Based Study.

The clinicopathological features and prognostic factors of gastric squamous cell carcinoma.

Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy

Suicide Rates among Patients with First and Second Primary Cancer.

Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502

Secondary primary malignancies among patients with GU cancer.

Effect of Second Primary Cancer on the Prognosis of Patients Wit H Non-Small Cell Lung Cancer

Survival Analysis of Second Primary Malignancies after Cervical Cancer Using a Competing Risk Model: Implications for Prevention and Surveillance.